These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3810477)

  • 21. Mast cell growth factor enhances multilineage hematopoietic recovery in vivo following radiation-induced aplasia.
    Patchen ML; Fischer R; Schmauder-Chock EA; Williams DE
    Exp Hematol; 1994 Jan; 22(1):31-9. PubMed ID: 7506673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NTP Toxicology and Carcinogenesis Studies of para-Chloroaniline Hydrochloride (CAS No. 20265-96-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 Jul; 351():1-256. PubMed ID: 12704433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A quantitative study on the recovery of rat marrow erythropoietic cells after experimental suppression of erythropoiesis by repeated doses of cyclophosphamide.
    Berger J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(2):255-63. PubMed ID: 6179828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetic examination of bone marrow cells and peripheral lymphocytes in rats exposed to cyclophosphamide.
    Topinková E; Srám RJ
    Folia Biol (Praha); 1982; 28(5):302-10. PubMed ID: 7173448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of cyclophosphamide on neuroblastoma and the bone marrow function in the experimental studies].
    Ohkawa M
    Hokkaido Igaku Zasshi; 1983 Nov; 58(6):561-74. PubMed ID: 6368346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of altering administration order of busulphan and cyclophosphamide on the myeloablative and immunosuppressive properties of the conditioning regimen in mice.
    Nilsson C; Forsman J; Hassan Z; Abedi-Valugerdi M; O'Connor C; Concha H; Jansson M; Hassan M
    Exp Hematol; 2005 Mar; 33(3):380-7. PubMed ID: 15730862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experiment study of efficacy on hematopoietic reconstitution and GVHD prophylaxis after mesenchymal cell infused by intra-bone marrow cavity or intravenous in rat BMT models].
    Huang K; Huang SL; Zhou DH; Cai Y; Zhang XC; Li Y
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):87-92. PubMed ID: 17650667
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined effects of interleukin-3 and interleukin-11 on hematopoiesis in irradiated mice.
    Galmiche MC; Vogel CA; Delaloye AB; Schmidt PM; Healy F; Mach JP; Buchegger F
    Exp Hematol; 1996 Sep; 24(11):1298-306. PubMed ID: 8862440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro and in vivo hematopoietic activities of Betafectin PGG-glucan.
    Patchen ML; Vaudrain T; Correira H; Martin T; Reese D
    Exp Hematol; 1998 Dec; 26(13):1247-54. PubMed ID: 9845381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of total body irradiation vs busulfan in combination with cyclophosphamide as conditioning for unrelated stem cell transplantation in CML patients.
    Kröger N; Zabelina T; Krüger W; Renges H; Stute N; Kabisch H; Jaburg N; Löliger C; Krüll A; Zander AR
    Bone Marrow Transplant; 2001 Feb; 27(4):349-54. PubMed ID: 11313663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mobilization of hematopoietic progenitor cells with paclitaxel (taxol) as a single chemotheraupetic agent, associated with rhG-CSF.
    Gómez-Espuch J; Moraleda JM; Ortuño F; Lozano ML; Ayala F; Vallejo C; de Arriba F; Vicente V
    Bone Marrow Transplant; 2000 Feb; 25(3):231-5. PubMed ID: 10673692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of IL-10 on murine CFU-pre-B formation.
    Fine JS; Macosko HD; Grace MJ; Narula SK
    Exp Hematol; 1994 Nov; 22(12):1188-96. PubMed ID: 7925782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of pretreatment with cyclophosphamide on high-dose toxicity of melphalan in mice.
    Kulkarni SS; Leventon GS; Huynh L; Chow H; Dicke KA; Zander AR
    Cancer Res; 1985 Nov; 45(11 Pt 1):5431-5. PubMed ID: 3902211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens.
    Bender JG; Lum L; Unverzagt KL; Lee W; Van Epps D; George S; Coon J; Ghalie R; McLeod B; Kaizer H
    Bone Marrow Transplant; 1994 Apr; 13(4):479-85. PubMed ID: 7517260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte-colony stimulating factor impedes recovery from damage caused by cytotoxic agents through increased differentiation at the expense of self-renewal.
    van Os R; Robinson S; Sheridan T; Mauch PM
    Stem Cells; 2000; 18(2):120-7. PubMed ID: 10742384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EPO receptor, Bax and Bcl-x(L) expressions in murine erythropoiesis after cyclophosphamide treatment.
    Juaristi JA; Aguirre MV; Todaro JS; Alvarez MA; Brandan NC
    Toxicology; 2007 Mar; 231(2-3):188-99. PubMed ID: 17254689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regeneration of erythroid progenitor cells in polycythemic mice treated with cyclophosphamide.
    Biljanović-Paunović L; Milenković P; Kapa D; Pavlović-Kentera V
    Exp Hematol; 1985 Jan; 13(1):67-73. PubMed ID: 3972018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-12 facilitates both the recovery of endogenous hematopoiesis and the engraftment of stem cells after ionizing radiation.
    Chen T; Burke KA; Zhan Y; Wang X; Shibata D; Zhao Y
    Exp Hematol; 2007 Feb; 35(2):203-13. PubMed ID: 17258069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Source of stem cells impacts on hematopoietic recovery after high-dose chemotherapy.
    Zimmerman TM; Mick R; Myers S; Bender JG; Lee WJ; Williams SF
    Bone Marrow Transplant; 1995 Jun; 15(6):923-7. PubMed ID: 7581092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Depletion of donor-reactive cells as a new concept for improvement of mismatched bone marrow engraftment using reduced-intensity conditioning.
    Prigozhina TB; Elkin G; Khitrin S; Slavin S
    Exp Hematol; 2004 Nov; 32(11):1110-7. PubMed ID: 15539090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.